GAMIFANT

This brand name is authorized in United States

Active ingredients

The drug GAMIFANT contains one active pharmaceutical ingredient (API):

1 Emapalumab UNII 3S252O2Z4X - EMAPALUMAB
Emapalumab is a monoclonal antibody that binds to and neutralizes interferon gamma (IFNγ). Nonclinical data suggest that IFNγ plays a pivotal role in the pathogenesis of HLH by being hypersecreted. Read about Emapalumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GAMIFANT Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 66658-501, 66658-505, 66658-510, 72171-501, 72171-505

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.